Arcticzymes Technologies ASA

B4V-FF:Frankfurt Stock Exchange
RT Quote | Exchange | EUR
Last | 01/18/21 CET
6.82UNCH (UNCH)
52 week range
0.47 - 7.82

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.82
  • 52 Week High7.82
  • 52 Week High Date10/09/20
  • 52 Week Low0.47
  • 52 Week Low Date03/12/20
  • Market Cap403.54M
  • Shares Out48.33M
  • 10 Day Average Volume1,254.27
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change1,226.85

RATIOS/PROFITABILITY

  • EPS (TTM)0.09
  • P/E (TTM)75.78
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Arcticzymes Technologies ASA News

There is no recent news for this security.

Latest B4V-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Arcticzymes Technologies ASA is a Norway-based biopharmaceutical company that develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. The Company focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including...
Marie Roskrow Ph.D.
Chairman
Jethro Holter
Chief Executive Officer
Borge Sorvoll
Chief Financial Officer
Address
Sykehusveien 23
Tromso
9019
Norway